Aptose Biosciences Inc.
Home
About
Overview
Management Team
Board of Directors
Scientific Advisory Board
Product Pipeline
Overview
Tuspetinib for AML
Luxeptinib for B-cell Tumors
Luxeptinib for Myeloid Tumors
Posters & Presentations
Clinical Trials
Overview
Luxeptinib for CLL & NHL
Luxeptinib for AML
Tuspetinib for AML
Expanded Access
News
Press Releases
Presentations
Events
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR
Governance
Join Us
Values & Culture
Perks & Benefits
Explore Careers
Contact
Posters & Presentations
Product Pipeline
Product Pipeline
Overview
Tuspetinib for AML
Luxeptinib for B-cell Tumors
Luxeptinib for Myeloid Tumors
Posters & Presentations
All
Poster
Presentation
December 3, 2016
Poster
ASH Poster
ASH Poster:
View Poster
December 6, 2015
Poster
ASH Poster 2015
ASH Poster 2015:
View Poster
December 5, 2015
Poster
Broad Activity of APTO-253 in AML and Other Hematologic Malignancies Correlates with KLF4 Expression Level
Broad Activity of APTO-253 in AML and Other Hematologic Malignancies Correlates with KLF4 Expression Level:
View Poster
May 8, 2014
Poster
2014 ASH Preclinical Update Poster
2014 ASH Preclinical Update Poster:
View Poster
May 1, 2014
Poster
2014 AACR Poster
2014 AACR Poster:
View Poster
May 2, 2013
Poster
2013 AACR PD Studies
2013 AACR PD Studies:
View Poster
May 1, 2013
Poster
2012 AACR Tumor Immunology Conference
2012 AACR Tumor Immunology Conference:
View Poster
May 1, 2013
Poster
2013 EEC ESMO Phase I Poster
2013 EEC ESMO Phase I Poster:
View Poster
May 1, 2012
Poster
2012 AACR Poster Combination Studies
2012 AACR Poster Combination Studies:
View Poster
Previous
1
2
3
4
5